GO
Loading...

Enter multiple symbols separated by commas

Pfizer Inc

More

  • NEW YORK/ LONDON, April 30- Pfizer Inc is the mystery bidder for Swedish Orphan Biovitrum AB, the rare disease specialist which disclosed this week that a potential buyer had made a preliminary offer, people with knowledge of the situation said. Sobi did not identify its potential acquirer when it revealed on Monday that it had received an approach, but Biogen and...

  • Final Glance: Pharmaceuticals companies Wednesday, 29 Apr 2015 | 6:14 PM ET

    Baxter International Inc. fell$. 48 or. 7 percent, to $69.75. Bristol-Myers Squibb Co. fell$. 25 or. 4 percent, to $64.29. Eli Lilly& Co. rose $1.10 or 1.5 percent, to $72.28.

  • Most active New York Stock Exchange-traded stocks Wednesday, 29 Apr 2015 | 2:53 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. fell. 3 percent to $34.76 with 39,838,600 shares traded. Bank of America Corp. rose 2.1 percent to $15.98 with 122,945,200 shares traded.

  • Midday Glance: Pharmaceuticals companies Wednesday, 29 Apr 2015 | 2:53 PM ET

    Baxter International Inc. fell$. 50 or. 7 percent, to $69.74. Bristol-Myers Squibb Co. fell$. 56 or. 9 percent, to $63.98. Eli Lilly& Co. rose$. 97 or 1.4 percent, to $72.15.

  • Dust off the weak economy trade: 5 buys Wednesday, 29 Apr 2015 | 12:23 PM ET
    Traders work the floor of the New York Stock Exchange.

    U.S. GDP figures stalled last quarter, setting up a winning short-term trade in certain sectors and slices of the stock market.

  • Early Glance: Pharmaceuticals companies Wednesday, 29 Apr 2015 | 10:45 AM ET

    Baxter International Inc. fell$. 31 or. 4 percent, to $69.92. Bristol-Myers Squibb Co. rose$. 19 or. 3 percent, to $64.73. Eli Lilly& Co. rose $1.00 or 1.4 percent, to $72.18.

  • Final Glance: Pharmaceuticals companies Tuesday, 28 Apr 2015 | 6:04 PM ET

    Baxter International Inc. fell$. 14 or. 2 percent, to $70.23. Bristol-Myers Squibb Co. fell$. 62 or 1.0 percent, to $64.54. Eli Lilly& Co. rose$. 29 or. 4 percent, to $71.18.

  • Pfizer Inc., Merck& Co. and Bristol-Myers Squibb Co., which reported first-quarter results Tuesday, all derive at least half their revenue from selling products overseas. Pfizer cut its 2015 earnings-per-share forecast by a nickel, to between $1.95 and $2.05, in the face of two fierce headwinds. New York- based Pfizer said those two factors will reduce 2015...

  • Traders work on the floor of the New York Stock Exchange.

    U.S.stocks closed mixed on Tuesday as investors eyed tech earnings and awaited the Federal Reserve's statement on Wednesday.

  • Most active New York Stock Exchange-traded stocks Tuesday, 28 Apr 2015 | 1:51 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AK Steel Holding Corp. rose 9.4 percent to $5.35 with 22,809,400 shares traded. AT&T Inc. rose 2.3 percent to $34.86 with 48,346,300 shares traded.

  • Midday Glance: Pharmaceuticals companies Tuesday, 28 Apr 2015 | 1:50 PM ET

    Baxter International Inc. fell$. 13 or. 2 percent, to $70.24. Bristol-Myers Squibb Co. fell$. 87 or 1.3 percent, to $64.29. Eli Lilly& Co. rose$. 29 or. 4 percent, to $71.18.

  • NEW YORK, April 28- A federal judge dismissed claims by former Elan Corp and Wyeth shareholders accusing billionaire investor Steven A. Cohen's SAC Capital Advisors LP of violating federal racketeering law by conducting insider trading in the drugmakers' stocks. District Judge Victor Marrero in Manhattan said the civil claims brought under the Racketeer...

  • Early Glance: Pharmaceuticals companies Tuesday, 28 Apr 2015 | 10:39 AM ET

    Baxter International Inc. fell$. 48 or. 7 percent, to $69.89. Bristol-Myers Squibb Co. fell $1.39 or 2.1 percent, to $63.77. Eli Lilly& Co. fell$. 20 or. 3 percent, to $70.70.

  • US STOCKS-Wall St fall as earnings disappoint Tuesday, 28 Apr 2015 | 10:13 AM ET

    *Merck on track for its best day since January 2014. Apple hit a record high before falling as much as 1.7 percent to $130.33 despite beating Wall Street's revenue and profit forecasts. Merck rose 4.8 percent to $59.85, on track for its best day since January 2014, after its diabetes drug, Januvia, achieved the main goal in a safety study.

  • Apple rose 1.7 percent to $134.87 in premarket trading after beating Wall Street's revenue and profit forecasts as it sold more iPhones in China. Coach shares slumped 5.2 percent to $40.15 after the handbag and accessories maker's quarterly sales fell short of estimates, while Ford Motor fell 1 percent to $15.88 after reporting a profit that was less than...

  • Dollar hits Pfizer; Merck 'blew away' estimates Tuesday, 28 Apr 2015 | 9:04 AM ET
    Tablets of Pfizer Inc.'s Lipitor and Merck & Co.'s Zocor.

    Pfizer reported a 4 percent drop in quarterly revenue, while Merck posted earnings that topped expectations.

  • Janet Yellen speaking on March 18, 2015.

    U.S. stock index futures indicated a flat open on Tuesday ahead of the two-day FOMC meeting, housing data and a busy day of earnings.

  • Innovation driving big pharma: Pro   Tuesday, 28 Apr 2015 | 8:09 AM ET
    Innovation driving big pharma: Pro

    Seamus Fernandez, Leerink Partners, and Barbara Ryan, Clermont Partners, share their thoughts on what's driving big pharma profits.

  • Merck 'blew away the quarter': Pro   Tuesday, 28 Apr 2015 | 8:05 AM ET
    Merck 'blew away the quarter': Pro

    Seamus Fernandez, Leerink Partners, and Barbara Ryan, Clermont Partners, break down the numbers on Pfizer's "ok" quarter, and Merck's "spectacular" results.

  • Early movers: BP, F, AAPL, BMY, COH, PFE & more Tuesday, 28 Apr 2015 | 8:01 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.